Lessons from genetic models of inflammatory bowel disease

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Over the past few years, application of targeted gene deletion and transgenic approaches has led to the often unanticipated development of rodent lines which develop inflammatory bowel disease. While none of these lines recapitulate the histopathological and clinical features usually associated with human inflammatory bowel disease (IBD) in their entirety, many exhibit key features comprising the development of 'spontaneous' chronic and acute inflammation. These models include targeted deletion of the genes encoding IL-2, IL-10, TGFβ, T-cell receptor α/β, keratin 8, and G12α. In addition, animals expressing transgenes for the human WA-B27 (with β-2 microglobulin) as well as a dominant negative construct which functionally blocks N-cadherin have also been observed to result in chronic inflammatory bowel disease. Most of the mutant murine lines experience a diffuse colitis, but some (HLA-B27 transgenic and IL-10-deficient) also experience small bowel inflammation. The variety of manipulations provides some important broad in sights: (1) IBD can result from dysregulation of mucosal immune responses or impairment of epithelial barrier function, and (2) the natural history of inflammation resulting from mutation at a single genetic loci is substantially modulated by other genetic factors. With the rapidly- increasing variety of mutant mice, comparison of the residual components of immune system in lines developing IBD with those of lines not developing IBD, it is possible to deduce a requirement for TCR γ/δ CD4+ lymphocytes as well as pivotal role of IFNγ and (as a suppressive factor) IL-10. Study of a number of models has demonstrated the important interaction between environmental factors and genetic predisposition. Thus, in at least some of the lines (IL-2-deficient and HLA-B27) the inflammatory bowel disease is not observed when the mutant mice are maintained in a germ-free environment but does develop after reconstitution with a pathogen-free flora. In the TCR α/β deficient mice, appendectomy in the neonatal period prevents the subsequent development of colitis. In still other models, inflammation may not occur without some challenge by an exogenous external agent, e.g., mice deficient in intestinal trefoil factor (ITF) exposed to dextran sodium sulfate (1). These models offer great promise to permit further dissection of the various constituents of the intestinal epithelium and mucosal immune response systems which are necessary for maintaining normal homeostasis and which can contribute to the development of inflammatory bowel disease. Further, they offer powerful tools for exploring the interaction between genetic and environmental factors to explicate the pathogenesis of inflammatory bowel disease and to develop new therapeutic intervention strategies.

Original languageEnglish (US)
Pages (from-to)163-165
Number of pages3
JournalActa Gastro-Enterologica Belgica
Volume60
Issue number2
StatePublished - Apr 1997

Fingerprint

Genetic Models
Inflammatory Bowel Diseases
Interleukin-10
Inflammation
HLA-B27 Antigen
Mucosal Immunity
Gene Deletion
Colitis
Interleukin-2
Immune System
Keratin-8
Dextran Sulfate
Genetic Loci
Appendectomy
Cadherins
Intestinal Mucosa
Genetic Predisposition to Disease
T-Cell Antigen Receptor
Transgenes
Crohn Disease

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Lessons from genetic models of inflammatory bowel disease. / Podolsky, D. K.

In: Acta Gastro-Enterologica Belgica, Vol. 60, No. 2, 04.1997, p. 163-165.

Research output: Contribution to journalArticle

@article{f60a20c9d35d4eaf8009dd7114184eca,
title = "Lessons from genetic models of inflammatory bowel disease",
abstract = "Over the past few years, application of targeted gene deletion and transgenic approaches has led to the often unanticipated development of rodent lines which develop inflammatory bowel disease. While none of these lines recapitulate the histopathological and clinical features usually associated with human inflammatory bowel disease (IBD) in their entirety, many exhibit key features comprising the development of 'spontaneous' chronic and acute inflammation. These models include targeted deletion of the genes encoding IL-2, IL-10, TGFβ, T-cell receptor α/β, keratin 8, and G12α. In addition, animals expressing transgenes for the human WA-B27 (with β-2 microglobulin) as well as a dominant negative construct which functionally blocks N-cadherin have also been observed to result in chronic inflammatory bowel disease. Most of the mutant murine lines experience a diffuse colitis, but some (HLA-B27 transgenic and IL-10-deficient) also experience small bowel inflammation. The variety of manipulations provides some important broad in sights: (1) IBD can result from dysregulation of mucosal immune responses or impairment of epithelial barrier function, and (2) the natural history of inflammation resulting from mutation at a single genetic loci is substantially modulated by other genetic factors. With the rapidly- increasing variety of mutant mice, comparison of the residual components of immune system in lines developing IBD with those of lines not developing IBD, it is possible to deduce a requirement for TCR γ/δ CD4+ lymphocytes as well as pivotal role of IFNγ and (as a suppressive factor) IL-10. Study of a number of models has demonstrated the important interaction between environmental factors and genetic predisposition. Thus, in at least some of the lines (IL-2-deficient and HLA-B27) the inflammatory bowel disease is not observed when the mutant mice are maintained in a germ-free environment but does develop after reconstitution with a pathogen-free flora. In the TCR α/β deficient mice, appendectomy in the neonatal period prevents the subsequent development of colitis. In still other models, inflammation may not occur without some challenge by an exogenous external agent, e.g., mice deficient in intestinal trefoil factor (ITF) exposed to dextran sodium sulfate (1). These models offer great promise to permit further dissection of the various constituents of the intestinal epithelium and mucosal immune response systems which are necessary for maintaining normal homeostasis and which can contribute to the development of inflammatory bowel disease. Further, they offer powerful tools for exploring the interaction between genetic and environmental factors to explicate the pathogenesis of inflammatory bowel disease and to develop new therapeutic intervention strategies.",
author = "Podolsky, {D. K.}",
year = "1997",
month = "4",
language = "English (US)",
volume = "60",
pages = "163--165",
journal = "Acta Gastro-Enterologica Belgica",
issn = "0001-5644",
publisher = "Universa Press",
number = "2",

}

TY - JOUR

T1 - Lessons from genetic models of inflammatory bowel disease

AU - Podolsky, D. K.

PY - 1997/4

Y1 - 1997/4

N2 - Over the past few years, application of targeted gene deletion and transgenic approaches has led to the often unanticipated development of rodent lines which develop inflammatory bowel disease. While none of these lines recapitulate the histopathological and clinical features usually associated with human inflammatory bowel disease (IBD) in their entirety, many exhibit key features comprising the development of 'spontaneous' chronic and acute inflammation. These models include targeted deletion of the genes encoding IL-2, IL-10, TGFβ, T-cell receptor α/β, keratin 8, and G12α. In addition, animals expressing transgenes for the human WA-B27 (with β-2 microglobulin) as well as a dominant negative construct which functionally blocks N-cadherin have also been observed to result in chronic inflammatory bowel disease. Most of the mutant murine lines experience a diffuse colitis, but some (HLA-B27 transgenic and IL-10-deficient) also experience small bowel inflammation. The variety of manipulations provides some important broad in sights: (1) IBD can result from dysregulation of mucosal immune responses or impairment of epithelial barrier function, and (2) the natural history of inflammation resulting from mutation at a single genetic loci is substantially modulated by other genetic factors. With the rapidly- increasing variety of mutant mice, comparison of the residual components of immune system in lines developing IBD with those of lines not developing IBD, it is possible to deduce a requirement for TCR γ/δ CD4+ lymphocytes as well as pivotal role of IFNγ and (as a suppressive factor) IL-10. Study of a number of models has demonstrated the important interaction between environmental factors and genetic predisposition. Thus, in at least some of the lines (IL-2-deficient and HLA-B27) the inflammatory bowel disease is not observed when the mutant mice are maintained in a germ-free environment but does develop after reconstitution with a pathogen-free flora. In the TCR α/β deficient mice, appendectomy in the neonatal period prevents the subsequent development of colitis. In still other models, inflammation may not occur without some challenge by an exogenous external agent, e.g., mice deficient in intestinal trefoil factor (ITF) exposed to dextran sodium sulfate (1). These models offer great promise to permit further dissection of the various constituents of the intestinal epithelium and mucosal immune response systems which are necessary for maintaining normal homeostasis and which can contribute to the development of inflammatory bowel disease. Further, they offer powerful tools for exploring the interaction between genetic and environmental factors to explicate the pathogenesis of inflammatory bowel disease and to develop new therapeutic intervention strategies.

AB - Over the past few years, application of targeted gene deletion and transgenic approaches has led to the often unanticipated development of rodent lines which develop inflammatory bowel disease. While none of these lines recapitulate the histopathological and clinical features usually associated with human inflammatory bowel disease (IBD) in their entirety, many exhibit key features comprising the development of 'spontaneous' chronic and acute inflammation. These models include targeted deletion of the genes encoding IL-2, IL-10, TGFβ, T-cell receptor α/β, keratin 8, and G12α. In addition, animals expressing transgenes for the human WA-B27 (with β-2 microglobulin) as well as a dominant negative construct which functionally blocks N-cadherin have also been observed to result in chronic inflammatory bowel disease. Most of the mutant murine lines experience a diffuse colitis, but some (HLA-B27 transgenic and IL-10-deficient) also experience small bowel inflammation. The variety of manipulations provides some important broad in sights: (1) IBD can result from dysregulation of mucosal immune responses or impairment of epithelial barrier function, and (2) the natural history of inflammation resulting from mutation at a single genetic loci is substantially modulated by other genetic factors. With the rapidly- increasing variety of mutant mice, comparison of the residual components of immune system in lines developing IBD with those of lines not developing IBD, it is possible to deduce a requirement for TCR γ/δ CD4+ lymphocytes as well as pivotal role of IFNγ and (as a suppressive factor) IL-10. Study of a number of models has demonstrated the important interaction between environmental factors and genetic predisposition. Thus, in at least some of the lines (IL-2-deficient and HLA-B27) the inflammatory bowel disease is not observed when the mutant mice are maintained in a germ-free environment but does develop after reconstitution with a pathogen-free flora. In the TCR α/β deficient mice, appendectomy in the neonatal period prevents the subsequent development of colitis. In still other models, inflammation may not occur without some challenge by an exogenous external agent, e.g., mice deficient in intestinal trefoil factor (ITF) exposed to dextran sodium sulfate (1). These models offer great promise to permit further dissection of the various constituents of the intestinal epithelium and mucosal immune response systems which are necessary for maintaining normal homeostasis and which can contribute to the development of inflammatory bowel disease. Further, they offer powerful tools for exploring the interaction between genetic and environmental factors to explicate the pathogenesis of inflammatory bowel disease and to develop new therapeutic intervention strategies.

UR - http://www.scopus.com/inward/record.url?scp=0030786887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030786887&partnerID=8YFLogxK

M3 - Article

C2 - 9260328

AN - SCOPUS:0030786887

VL - 60

SP - 163

EP - 165

JO - Acta Gastro-Enterologica Belgica

JF - Acta Gastro-Enterologica Belgica

SN - 0001-5644

IS - 2

ER -